Instructional Video9:35
Neuro Transmissions

UCSD Scientists Explain How They Spend NIH Funds

12th - Higher Ed
President Trumpês proposed budget will cut $7 billion in NIH funding - over 20% of the total NIH budget. You might be wondering, where does that NIH money get spent? This week, we interviewed some UCSD Neuroscientists to tell you about...
Instructional Video8:41
Neuro Transmissions

How the NIH Funds American Science

12th - Higher Ed
President Trumpês proposed budget will cut $7 billion in NIH funding - over 20% of the total NIH budget. You might be wondering, where does NIH money go? This week, we heard from scientists across the country about their NIH funded...
Instructional Video7:05
Healthcare Triage

Women and Minorities Get Fewer NIH Research Grants

Higher Ed
The peer review process for awarding NIH grants has some problems. Less money is being awarded, and the buying power of the NIH has declined. What's going on with the peer review system?
Instructional Video6:09
Curated Video

How Hearing Works - Journey of Sound to the Brain

Higher Ed
How do we hear? How does sound get transferred from the ear all the way to the brain? In this video, I go into all the juicy details. Listen up and have fun.
Instructional Video8:13
Neuro Transmissions

What Are Overhead Payments?

12th - Higher Ed
The administration has proposed a cut of nearly $6 billion to the NIH budget in 2018. They say that no research will be directly affected because the NIH budget will trim –inefficient,” "wasteful" overhead payments. But what are those...
News Clip2:11
Curated Video

Push to better understand the long-term harms of opioid use

9th - Higher Ed
Canada's opioid crisis is prompting calls for more research into the long-term harms of opioid abuse in order to better equip the health-care system and help people recover and heal.
News Clip2:11
Curated Video

More research needed on health of long-term opioid users, medical experts say

9th - Higher Ed
People who have used opioids long-term suffer from an array of complications that require extra medical care. But that same present or even past drug use can limit the types of treatments available. Many doctors say study is needed on...
News Clip4:41
Curated Video

NIH Director: U.S. Could Soon See 200K New COVID Cases a Day

9th - Higher Ed
NIH Director Francis Collins issued a stark warning, predicting that the U.S. will soon see 200,000 COVID-19 cases per day — a level not seen since last winter. It comes amid a rise in cases fueled by the highly contagious delta variant....
News Clip2:00
Curated Video

Antiviral drug remdesivir shows promise as COVID-19 treatment

9th - Higher Ed
The antiviral drug remdesivir is showing promise as a COVID-19 treatment in early U.S. clinical trials, though other research hasn’t seen as much success.
News Clip1:20
AFP News Agency

CLEAN : Ebola concerns continue as sick nurse leaves Texas hospital

9th - Higher Ed
CLEAN : Ebola concerns continue as sick nurse leaves Texas hospital
News Clip4:36
Curated Video

Brain Injuries From Combat Get New Attention After Missile Attack

Higher Ed
More than 400,000 service members suffered traumatic brain injuries in Iraq and Afghanistan. Most returned to duty. Many will have enduring symptoms.
News Clip6:51
Curated Video

How Long COVID Is Affecting Millions Of Americans' Wallets

Higher Ed
One study found that more than half of U.S. adults who got COVID or lost income during the pandemic struggle with medical debt.
News Clip2:37
Curated Video

Could Artificial Intelligence Help Patients With Schizophrenia?

Higher Ed
An app that uses artificial intelligence to measure thinking and speech patterns could help patients with schizophrenia.
News Clip2:32
Curated Video

Possible Coronavirus Treatments Include Cloned Antibodies, Vaccines

Higher Ed
While the CDC says risk to Americans is still low, U.S. researchers and scientists are hard at work exploring possible treatments for coronavirus.
News Clip1:26
Curated Video

NIH Says Experimental HIV Vaccine Has Been Found Ineffective

Higher Ed
An interim review of a clinical trial in South Africa showed the vaccine had virtually no impact on infection rates.
News Clip1:26
Curated Video

NIH Says Experimental HIV Vaccine Has Been Found Ineffective

Higher Ed
An interim review of a clinical trial in South Africa showed the vaccine had virtually no impact on infection rates.
News Clip3:08
Curated Video

Largest COVID-19 Vaccine Trial Underway

Higher Ed
This week, researchers began testing 30,000 test subjects in the NIH’s and drugmaker Moderna’s Phase 3 clinical trials on a virus vaccine.
News Clip1:44
Curated Video

Therapeutic Drug Could Help Keep COVID-19 Patients Off Ventilators

Higher Ed
AT-100 could help keep COVID-19 patients from going into respiratory distress and off of ventilators.
News Clip1:57
Curated Video

How $25M Can Improve What We Know About Gun Violence

Higher Ed
Lawmakers approved $25 million for the CDC and the NIH. It's the first time Congress has authorized funding for gun violence research in decades.
News Clip2:29
Bloomberg

Trump Says Americans Should Only Gather in Groups of 10 or Less

Higher Ed
Mar.16 -- President Donald Trump unveils new guidelines issued to fight the coronavirus. He speaks at the White House.
News Clip1:10
Bloomberg

AstraZeneca Vaccine Trial Halted After Spinal-Cord Issue

Higher Ed
Sep.09 -- National Institutes of Health Director Francis Collins says AstraZeneca Plc’s closely watched Covid-19 vaccine trial had been halted due to a "spinal cord problem." He speaks at a congressional hearing . (Excerpt)
News Clip0:57
Curated Video

Clinical Trial For Coronavirus Vaccine Will Begin Monday

Higher Ed
An anonymous government official told the Associated Press the trial's first participant will receive an experimental dose of the vaccine Monday.
News Clip1:13
Curated Video

Study: Coronavirus Can Remain Viable On Some Surfaces For Days

Higher Ed
It can remain viable anywhere from three hours in the air to up to three days on plastic and stainless steel surfaces.
News Clip1:01
Curated Video

Trial Finds Remdesivir As Beneficial COVID-19 Drug, NIH Says

Higher Ed
The NIH says the drug cut the recovery time of patients by four days when compared to patients receiving a placebo